← Stack Research Tool

Pair page

Cartalax with Epithalon

Mechanism-tag overlap and published literature for Cartalax and Epithalon, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.

Mechanism overlap

Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.

CARTALAX EPITHALON 1 UNIQUE TAGS 1 UNIQUE TAGS 0 SHARED
Cartalax unique khavinson-cartilage-bioregulator
Shared none
Epithalon unique pineal-tetrapeptide-khavinson-bioregulator

Co-administration notes from the literature

Verbatim summary text pulled from each compound's profile data. Researchers studying Cartalax and Epithalon have published these mechanism-level observations. Not a co-administration recommendation.

Evidence level: mechanistic only

Commonly included in the broader Khavinson longevity stack alongside tissue-specific peptides such as Cartalax.

Quick facts

Cartalax

RouteOral / SubQ / IM
Half-lifeNot listed
FDA statusNot approved
WADANot specifically listed
Full Cartalax profile →

Epithalon

RouteSubQ / IM / intranasal
Half-life~30 min plasma; functional effect weeks–months
FDA statusNot approved
WADANot specifically named
Full Epithalon profile →

Literature table

Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.

Year Compound Source Finding
2021CartalaxKhavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053. PMID: 34834147. PMID 34834147systematic review
2006CartalaxGumen AV, Kozinets IA, Shanin SN, Malinin VV, Rybakina EG. Production of lymphocyte-activating factors by mouse macrophages during aging and under the effect of short peptides. Bulletin of Experimental Biology and Medicine. 2006;142(3):360-362. PMID: 17266159. PMID 17266159preclinical, in vivo
2016CartalaxLinkova NS, Drobintseva AO, Orlova OA, Kuznetsova EP, Polyakova VO, Kvetnoy IM, Khavinson VKh. Peptide regulation of skin fibroblast functions during their aging in vitro. Bulletin of Experimental Biology and Medicine. 2016;161(1):175-178. PMID: 27259486. PMID 27259486preclinical, in vitro
2014CartalaxKhavinson VKh, Tarnovskaya SI, Lin'kova NS, Polyakova VO, Durnova AO, Nichik TE, Kvetnoi IM, D'yakonov MM, Yakutseni PP. Short cell-penetrating peptides regulate fibroblast functions in cell cultures of young and old patients. Advances in Gerontology. 2014;27(4):651-656. (Key Ca…preclinical, in vitro
2011CartalaxFedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and the specific interaction of the peptides with deoxyribooligonucleotides and DNA in vitro. Biochemistry (Moscow). 2011;76(11):1210-1219. PM… PMID 22117548preclinical, in vitro
2012CartalaxKhavinson VKh, Solov'ev AIu, Zhilinskii DV. Molecular mechanism of the peptide regulation of gene expression: a review. Advances in Gerontology. 2012;25(3):447-456. PMID: 23289233. PMID 23289233mechanism / discovery
2020CartalaxKhavinson V, Linkova N, Diatlova A, Trofimova S. Peptide Regulation of Cell Differentiation. Stem Cell Reviews and Reports. 2020;16(1):118-125. PMID: 31813120. PMID 31813120bioregulator literature
2016CartalaxVanyushin BF, Khavinson VKh. Short Biologically Active Peptides as Epigenetic Modulators of Gene Activity. In: Epigenetics — A Different Way of Looking at Genetics. Springer, 2016. DOI: 10.1007/978-3-319-27186-6_5.bioregulator literature
2012CartalaxKhavinson VKh, Linkova NS, Polyakova VO, Kheifets OV, Tarnovskaya SI, Kvetnoy IM. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine. 2012;153(1):148-151. PMID: 22808513. PMID 22808513bioregulator literature
2010CartalaxAnisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149. PMID: 19633997. PMID 19633997bioregulator literature
2005CartalaxKhavinson VKh, Malinin VV. Gerontological Aspects of Genome Peptide Regulation. Karger Publishers, Basel, 2005. ISBN 3-8055-7903-3.bioregulator literature
2002CartalaxKhavinson VKh. Peptides and ageing. Neuroendocrinology Letters. 2002;23(Suppl 3):11-144. PMID: 12496732. PMID 12496732bioregulator literature
2010EpithalonKorkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IA. Peptide geroprotector Epitalamin: effects on vascular endothelial function in elderly patients. Adv Gerontol. 2010;23(3):440-446.human study
2004EpithalonKhavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004;137(5):503-506.human study
2003EpithalonKhavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-240. PMID: 14523363. (266-patient elderly mortality cohort.) PMID 14523363human study
2021EpithalonKhavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mikhailova N, Petukhov M. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel). 2021;14(6):515.preclinical, in vivo
2004EpithalonLabunets IF, Butenko GM, Dragunova VA, Magdich LV, Khavinson VKh. Effect of epithalamin, thymalin, and tocopherol on age-associated involution of the pineal gland in rats. Bull Exp Biol Med. 2004;137(5):510-512.preclinical, in vivo
2003EpithalonAnisimov VN, Khavinson VKh, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4)… PMID 14501183preclinical, in vivo
2003EpithalonKossoy G, Zandbank J, Tendler E, Anisimov V, Khavinson V, Popovich I, Zabezhinski M, Zusman I, Ben-Hur H. Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. Int J Mol Med. 2003;12(4):473-477. PMID: 12964019. PMID 12964019preclinical, in vivo
2025EpithalonAl-Dulaimi MS, et al. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. 2025. PMID: 40908429. PMC12411320. (Modern Western-lab replication of the central telomerase-activation claim.) PMID 40908429mechanism / discovery
2017EpithalonKhavinson V, Popovich I. Short peptides regulate gene expression, protein synthesis and enhance life span. In: Understanding the Aging Process and Age-Related Diseases. Academic Press; 2017.mechanism / discovery
2016EpithalonKhavinson VKh, Linkova NS, Tarnovskaia SI. Short peptides regulate gene expression. Bull Exp Biol Med. 2016;162(2):288-292.mechanism / discovery
2003EpithalonKhavinson VKh, Bondarev IE, Butyugov AA. Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells. Bull Exp Biol Med. 2003;135(6):590-592. PMID: 12937682. PMID 12937682mechanism / discovery
2017EpithalonKhavinson VKh, Kopylov AT, Vaskovsky BV, Ryzhak GA, Lin'kova NS. Identification of peptide AEDG in the polypeptide complex of the pineal gland. Bull Exp Biol Med. 2017;164(1):41-43.bioregulator literature

Related pair pages

More research context

Frequently asked

Have Cartalax and Epithalon been studied together?

Researchers have published mechanistic-level co-administration discussion of Cartalax and Epithalon. No human co-administration trials are catalogued in the Kalios profiles. The pair page lists each compound's classified literature; full citations sit on each individual profile.

What mechanisms do Cartalax and Epithalon share?

Cartalax and Epithalon do not share a specific mechanism tag on their Kalios profiles. They appear on the same pair page because at least one profile lists the other in its co-administration data.

What is the FDA status of Cartalax and Epithalon?

Cartalax: Not approved. Epithalon: Not approved. FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.

Where can I find the full research on Cartalax and Epithalon?

Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the Cartalax profile and the Epithalon profile. The Kalios Stack Research Tool hub lists every compound covered.

Last updated: April 2026